MVM funds lift MDxHealth (NASDAQ: MDXH) stake to 6.9M shares

Rhea-AI Filing Summary

MDxHealth SA (MDXH) reports that private investment vehicles managed by MVM Partners, LLC purchased 2,202,643 Ordinary Shares at $0.454 per share on August 13, 2026, under securities purchase agreements dated August 11, 2026. Following this transaction, these funds hold 6,903,100 Ordinary Shares. The shares are owned directly by the funds and reported as indirectly owned by MVM Partners and Eric Bednarski, who each disclaim beneficial ownership except to the extent of any pecuniary interest.

Insider Trade Summary

Net Buyer: 2,202,643 shares

Net Buy 1 txn

Insider MVM Partners, LLC, Bednarski Eric

Role Director | Director

Bought 2,202,643 shs ($1000K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares F1, F2	2,202,643	$0.454	$1000K

Holdings After Transaction: Ordinary Shares — 6,903,100 shares (Indirect, See Footnote)

Footnotes (2)

1. F1. Ordinary shares, no par value, of MDxHealth SA (the "Issuer") purchased pursuant to securities purchase agreements by and between the Issuer and certain private investment vehicles managed by MVM Partners, LLC (the "Funds"), each dated as of August 11, 2026.
2. F2. The securities reported herein are directly owned by the Funds. The securities may also be deemed beneficially owned by MVM Partners, LLC ("MVM") as the investment manager of the Funds and by Eric Bednarski as Managing Member of MVM. Each of Mr. Bednarski and MVM disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests therein, if any, and this Form 4 shall not be deemed an admission that either Mr. Bednarski or MVM is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Key Figures

Shares purchased: 2,202,643 shares Purchase price per share: $0.454 per share Shares held after transaction: 6,903,100 shares

3 metrics

Shares purchased 2,202,643 shares Ordinary Shares acquired on August 13, 2026

Purchase price per share $0.454 per share Price for the 2,202,643 Ordinary Shares purchased

Shares held after transaction 6,903,100 shares Ordinary Shares held by the MVM-managed funds following the reported purchase

Key Terms

securities purchase agreements, beneficially owned, pecuniary interests

3 terms

securities purchase agreements financial

"purchased pursuant to securities purchase agreements by and between the Issuer"

A securities purchase agreement is a legal contract that spells out the terms when a company sells stocks, bonds, or other investment instruments to buyers. It lays out price, how many securities change hands, any promises or protections for each side, and when the sale is completed—like a detailed sales contract for investments. Investors care because it determines ownership stakes, potential dilution, rights attached to the securities, and conditions that affect the company’s future value.

beneficially owned financial

"The securities may also be deemed beneficially owned by MVM Partners, LLC"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

pecuniary interests financial

"disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests"

FAQ

What did MVM Partners report in this Form 4 for MDXH?

MVM-managed funds purchased 2,202,643 MDxHealth SA Ordinary Shares on August 13, 2026 at $0.454 per share. After this transaction, the funds hold 6,903,100 Ordinary Shares reported as indirect holdings for MVM Partners and Eric Bednarski.

What was the purchase price of MDXH shares in the reported transaction?

The funds bought MDXH Ordinary Shares at $0.454 per share. This price applies to the 2,202,643 shares acquired on August 13, 2026 under securities purchase agreements dated August 11, 2026 with MDxHealth SA.

How many MDXH shares do the MVM-managed funds hold after this Form 4 transaction?

After the reported purchase, the MVM-managed funds hold 6,903,100 MDXH Ordinary Shares. These holdings are reported as indirectly owned by MVM Partners, LLC and Eric Bednarski, who each disclaim beneficial ownership beyond any pecuniary interests.

Who is considered to own the MDXH shares reported in this Form 4?

The MDXH shares are directly owned by private investment funds managed by MVM Partners. They may be deemed beneficially owned by MVM Partners and Eric Bednarski, but both disclaim beneficial ownership except to the extent of any pecuniary interests.

Were the MDXH share purchases by MVM Partners under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked as affirmative. The transaction is instead described as shares purchased pursuant to securities purchase agreements dated August 11, 2026 between MDxHealth SA and the MVM-managed funds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 04:05 PM Accepted by SEC EDGAR 08/17/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MVM Partners, LLC

(Last) (First) (Middle)

OLD CITY HALL

45 SCHOOL STREET

(Street)

BOSTON MASSACHUSETTS 02108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MDxHealth SA [ MDXH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/13/2026		P(1)		2,202,643	A	$0.454	6,903,100	I	See Footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

MVM Partners, LLC

(Last) (First) (Middle)

OLD CITY HALL

45 SCHOOL STREET

(Street)

BOSTON MASSACHUSETTS 02108

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Bednarski Eric

(Last) (First) (Middle)

CAP BUSINESS CENTER

ZONE INDUSTRIELLE DES HAUTS-SARTS

(Street)

HERSTAL 4040

(City) (State) (Zip)

BELGIUM

(Country)

Relationship of Reporting Person(s) to Issuer

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Ordinary shares, no par value, of MDxHealth SA (the "Issuer") purchased pursuant to securities purchase agreements by and between the Issuer and certain private investment vehicles managed by MVM Partners, LLC (the "Funds"), each dated as of August 11, 2026.

2. The securities reported herein are directly owned by the Funds. The securities may also be deemed beneficially owned by MVM Partners, LLC ("MVM") as the investment manager of the Funds and by Eric Bednarski as Managing Member of MVM. Each of Mr. Bednarski and MVM disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interests therein, if any, and this Form 4 shall not be deemed an admission that either Mr. Bednarski or MVM is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

	/s/ Mark Busch, as attorney-in-fact for MVM Partners, LLC	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)